Intracept

Device Relievant Medsystems, Inc.
Total Payments
$8.1M
Transactions
34,008
Doctors
7,131
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $597,987 4,837 1,806
2023 $2.3M 14,298 3,714
2022 $2.0M 7,692 2,557
2021 $917,082 4,714 1,793
2020 $314,023 1,143 463
2019 $2.1M 1,324 484

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.3M 283 27.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2.2M 1,449 27.0%
Travel and Lodging $1.5M 5,358 18.4%
Food and Beverage $1.5M 26,553 18.0%
Consulting Fee $700,815 365 8.6%

Payments by Type

General
$5.9M
33,725 transactions
Research
$2.3M
283 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
INTRACEPT Relievant Medsystems, Inc. $1.0M 0
CLBP Single Arm Case Series Relievant Medsystems, Inc. $494,065 0
ISR 0010 Meta Analysis Intracept vs Non Surgical Pain Intervention Relievant Medsystems, Inc. $176,489 0
Intracept Relievant Medsystems, Inc. $138,062 0
Single Arm Cohort Study Relievant Medsystems, Inc. $94,893 0
SMART 5 Plus Year Follow-up Study Relievant Medsystems, Inc. $90,552 0
HECON Utilization Analysis Relievant Medsystems, Inc. $25,908 0
ISR 0007 Intracept Registry Pilot Phase II Relievant Medsystems, Inc. $25,713 0
Pain Characteristics Relievant Medsystems, Inc. $25,395 0
Imaging Characteristics Study Relievant Medsystems, Inc. $21,300 0
Meta-Analysis Relievant Medsystems, Inc. $20,475 0
ISR 0003 Intracept Registry Pilot Relievant Medsystems, Inc. $18,888 0
CLBP Single Arm 5 Year Follow Up Relievant Medsystems, Inc. $16,455 0
VERTEBROGENIC PAIN PATIENT CHARACTERISTS Relievant Medsystems, Inc. $15,775 0
ISR 0006 Pain Body Diagram Mapping Relievant Medsystems, Inc. $14,529 0
ISR 0009 Vertebrogenic Pain Imaging Characteristics Relievant Medsystems, Inc. $14,529 0
Patient Characteristics manuscript Relievant Medsystems, Inc. $13,110 0
Targeted Ablation Zone MRI Study Relievant Medsystems, Inc. $12,985 0
ISR 0002 Patient Characteristics Regression Relievant Medsystems, Inc. $11,116 0
Intracept Case Series_TBI Relievant Medsystems, Inc. $10,707 0

Top Doctors Receiving Payments for Intracept

Doctor Specialty Location Total Records
Unknown Lebanon, NH $2.3M 285
, M.D Pain Medicine Carmel, IN $289,058 255
, MD Orthopaedic Surgery Southfield, MI $229,176 96
, D.O Anesthesiology East Setauket, NY $202,515 367
, M.D Pain Medicine San Francisco, CA $191,325 248
, M.D Interventional Pain Medicine Eugene, OR $179,970 183
, D.O Pain Medicine Stony Brook, NY $163,762 343
, D.O Pain Medicine Port Charlotte, FL $148,445 214
, M.D Orthopaedic Surgery Southfield, MI $129,634 102
, MD Physical Medicine & Rehabilitation Charlotte, NC $128,526 181
, MD Neuroradiology Boston, MA $125,088 96
, MD Spinal Cord Injury Medicine Fort Lauderdale, FL $117,399 197
, MD Physical Medicine & Rehabilitation Plymouth, MN $111,739 197
, MD Orthopaedic Surgery Los Angeles, CA $110,364 146
, RN, ANP Gerontology Port Jefferson, NY $109,609 402
, MD Orthopaedic Surgery New Haven, CT $104,187 58
, MD Orthopaedic Surgery of the Spine Charlotte, NC $88,312 79
, NP Family Killeen, TX $69,180 213
Brian Goentzel Pain Medicine Wichita, KS $66,831 95
, PA Medical Plymouth, MN $59,109 205
, D.O Pain Medicine Germantown, MD $57,747 102
, D.O Physical Medicine & Rehabilitation Stockton, CA $56,491 152
, MD Pain Medicine Austin, TX $49,031 90
, M.D Student in an Organized Health Care Education/Training Program Draper, UT $42,909 120
, MD Pain Medicine Cleveland, OH $42,631 9

About Intracept

Intracept is a device associated with $8.1M in payments to 7,131 healthcare providers, recorded across 34,008 transactions in the CMS Open Payments database. The primary manufacturer is Relievant Medsystems, Inc..

Payment data is available from 2019 to 2024. In 2024, $597,987 was paid across 4,837 transactions to 1,806 doctors.

The most common payment nature for Intracept is "Unspecified" ($2.3M, 27.9% of total).

Intracept is associated with 20 research studies, including "INTRACEPT" ($1.0M).